Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, the Financial Times reported on Monday, citing people familiar with the matter.

Type 1 diabetes (T1D) is an autoimmune condition where the immune system destroys insulin-producing β-cells in the pancreas.

One of the first brain cells shown to make insulin is the neurogliaform cell. These live in a brain area important for ...

Officials at the FDA say they want to speed up approvals for new drugs and devices using tech like the new "Elsa" AI system. More news is on other uses of AI in health care, Eli Lilly refusing to work ...

Scientists developed an interactive artificial pancreas that uses digital twins to improve blood sugar control in type 1 diabetes patients.

New digital twin technology that allows a University of Virginia-developed artificial pancreas system to adapt to users' ...

New technology that allows a University of Virginia-developed artificial pancreas system to adapt to users' changing bodies – ...

Social media users agreed with the traveler in the viral post, with one saying "the quality of our food is garbage." ...

A ‘digital twin’ for diabetes control helps users with Type 1 diabetes with UVA-developed artificial pancreases, a new study ...

So a healthy skepticism toward any pronouncements about how artificial intelligence (AI ... including technological and policy decisions made today. For each area, we present a fork in the road: two ...

a type of synthetic insulin made in a laboratory that mimics the insulin our body makes. Over the last 15-20 years, insulin analogues, which are more convenient and quicker to act, have been in use in ...

This is how The Washington Post, in consultation with AI experts, detected the use of artificial intelligence in the initial version of the report provided to journalists.